Zion Market Research has released a report on the Medical Radiation Shielding Market, predicting growth from $1.6 billion in 2024 to $3.2 billion by 2034, with a 7.20% CAGR. The industry uses various materials to protect against ionizing radiation during medical procedures, with lead-based shielding being the most common for attenuation.

Key insights suggest that the market share will grow at a 7.20% CAGR, reaching $3.2 billion by 2034, driven by the increased prevalence of cancer and cardiovascular disease. X-ray shields, lead-based shielding, diagnostics, and hospitals & clinics are expected to dominate the market, with North America leading in market share.

The report segments the global medical radiation shielding market by product type, material, application, end-use, and region. X-ray shields, lead-based shielding, diagnostics, and hospitals & clinics are expected to lead their respective segments. North America is forecasted to dominate the market due to advanced healthcare systems and high rates of cancer.

The rising incidence of chronic diseases, particularly cancer and heart disease, is fueling the growth of the medical radiation shielding market. As more people undergo diagnostic imaging procedures involving ionizing radiation, demand for effective shielding solutions to protect patients and healthcare workers is increasing, driven by projections of rising cancer cases.

The global medical radiation shielding market is expected to see significant growth, with X-ray shields, lead-based shielding, diagnostics, and hospitals & clinics playing key roles. North America is projected to lead the market due to established healthcare systems and high demand for radiation-based diagnostics and treatments, necessitating robust shielding solutions.

Read more at GlobeNewswire: Medical Radiation Shielding Market Size Is Valued At USD